PanGen Biotech Inc. (KOSDAQ:222110)
South Korea · Delayed Price · Currency is KRW 6,180.00
+130.00 (2.15%)
Last updated: Aug 6, 2025
PanGen Biotech Company Description
PanGen Biotech Inc. operates as a biologics company in South Korea.
It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc. The company also provides CHO cell lines for proteins and monoclonal antibodies; and one-stop services ranging from producer cell line development to GMP production.
In addition, it offers reagents, quantitation kits, and cell based assay systems, as well as technology transfer service.
PanGen Biotech Inc. was founded in 1999 and is based in Suwon-si, South Korea.
PanGen Biotech Inc.
| Country | South Korea |
| Founded | 1999 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: Innoplex 2-dong Suwon-si, 16675 South Korea | |
| Phone | 82 3 1733 9165 |
| Website | pangen.com |
Stock Details
| Ticker Symbol | 222110 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |